← All trials
NCT04895059
Phase 1Interventional
Includes initial studies to determine the metabolism and pharmacologic actions of drugs in humans, the side effects associated with increasing doses, and to gain early evidence of effectiveness; may include healthy participants and/or patients.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Apr 30, 2017
- Primary completion
- Jan 15, 2018
- Completion date
- Jan 22, 2018
- First posted
- May 20, 2021
- Last posted
- Aug 24, 2021
- Enrollment
- 36
- Arms / groups
- 3 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Laboratorios Silanes S.A. de C.V.Lead sponsor
- Instituto de Investigacion de las Alteraciones del Crecimiento, Desarrollo y Enfermedades MetabolicasOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.